Covidien Gains Capnography Market Leader Oridion Via $300 Mil. Acquisition
This article was originally published in The Gray Sheet
Newly acquired Oridion Microstream exhaled carbon dioxide measurement technology dovetails with Covidien’s pulse oximetry and other patient monitoring products.
You may also be interested in...
Medical device company financing brought in $977 million, a decrease over Q1’s $1.1 billion. Device acquisition activity was up to $4.6 billion, yet only one deal surpassed the billion-dollar mark. With late-stage financing again leading, diagnostics funding together brought in $336 million, an 11% increase over Q1. For the first time since Q1 2011, the diagnostics M&A dollar total moved up instead of down, with $7 billion in acquisitions and five of the seven transactions topping $100 million.
Teleflex buys Semprus BioSciences. CDC pilots HIV testing at retail clinics. Covidien closes Oridion deal. More news briefs.
Smith & Nephew launches orthobiologics spinout. CMS proposes CED for wound care gel. More news briefs.